SerpinA3i inhibitors are a class of compounds that specifically target and inhibit the activity of the protein SerpinA3, also known as alpha-1-antichymotrypsin. SerpinA3 belongs to the serine protease inhibitor (serpin) superfamily, a group of proteins that regulate proteolytic enzymes involved in a wide range of physiological processes such as inflammation, immune responses, and cellular remodeling. SerpinA3, in particular, inhibits chymotrypsin-like serine proteases, enzymes that play key roles in the degradation of proteins. SerpinA3i inhibitors function by interfering with the inhibitory mechanism of SerpinA3, preventing it from binding to and neutralizing target proteases, which in turn allows the proteases to remain active. This mechanism of inhibition can significantly impact the regulatory balance of proteolysis in various biological contexts, such as extracellular matrix breakdown or immune cell activation.
Structurally, SerpinA3i inhibitors are diverse and can include small molecules, peptides, or engineered proteins designed to selectively bind to the reactive center loop of SerpinA3, the domain responsible for interacting with proteases. By stabilizing or modifying this reactive loop, SerpinA3i inhibitors can modulate the inhibitory function of SerpinA3 with high specificity. This inhibition can lead to a cascade of biochemical events, where the altered activity of target proteases affects downstream processes like cell migration, matrix remodeling, or signal transduction. Research into SerpinA3 inhibitors often explores the biochemical pathways regulated by this protein, providing insights into the complex interactions between proteases and their inhibitors, as well as the broader physiological roles of serpin family proteins.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, a kinase involved in multiple signaling pathways, which can alter SerpinA3i activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, potentially affecting SerpinA3i regulation by altering signaling pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which may influence SerpinA3i activity by modifying cellular stress responses. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which could affect SerpinA3i activity through the MAPK/ERK pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, potentially affecting SerpinA3i by altering inflammatory response pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which can modify SerpinA3i activity by affecting the cellular growth control pathway. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Inhibits proteasome, which may indirectly influence SerpinA3i by altering protein degradation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor, which can affect SerpinA3i levels by changing proteolytic pathways. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
Inhibits caspases, potentially affecting SerpinA3i by modulating apoptosis-related processes. | ||||||
Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 | 612847-09-3 | sc-202048 sc-202048A | 1 mg 5 mg | $208.00 $270.00 | 29 | |
Inhibits AKT, potentially affecting SerpinA3i signaling by altering cell survival pathways. | ||||||